Gene · 9112
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma. | Front Oncol | 2022 | 36324575 | PubTator, text mining | PubMed |
| Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking. | Sci Rep | 2022 | 36319798 | PubTator, text mining | PubMed |
| The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31. | Front Oncol | 2022 | 36313626 | PubTator, text mining | PubMed |
| Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment. | Subcell Biochem | 2022 | 36301490 | PubTator, text mining | PubMed |
| Innate Immunity, Inflammation, and Intervention in HBV Infection. | Viruses | 2022 | 36298831 | PubTator, text mining | PubMed |
| The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer. | Cancers (Basel) | 2022 | 36291918 | PubTator, text mining | PubMed |
| Nuclear Proteomics of Induced Leukemia Cell Differentiation. | Cells | 2022 | 36291090 | PubTator, text mining | PubMed |
| Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. | Cancer Commun (Lond) | 2022 | 36266736 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. | Adv Sci (Weinh) | 2022 | 36253096 | PubTator, text mining | PubMed |
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs. | Oncotarget | 2022 | 36243940 | PubTator, text mining | PubMed |
| The Anticancer Potential of Plant-Derived Nutraceuticals via the Modulation of Gene Expression. | Plants (Basel) | 2022 | 36235389 | PubTator, text mining | PubMed |
| The Role of FOXP3 on Tumor Metastasis and Its Interaction with Traditional Chinese Medicine. | Molecules | 2022 | 36235242 | PubTator, text mining | PubMed |
| Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Int J Mol Sci | 2022 | 36233152 | PubTator, text mining | PubMed |
| Polyphenols as Potent Epigenetics Agents for Cancer. | Int J Mol Sci | 2022 | 36233012 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Regulation of Metastasis in Ewing Sarcoma. | Cancers (Basel) | 2022 | 36230825 | PubTator, text mining | PubMed |
| H3F3A K27M Mutation Promotes the Infiltrative Growth of High-Grade Glioma in Adults by Activating β-Catenin/USP1 Signaling. | Cancers (Basel) | 2022 | 36230759 | PubTator, text mining | PubMed |
| A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer. | Cancers (Basel) | 2022 | 36230649 | PubTator, text mining | PubMed |
| Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer. | J Biosci | 2022 | 36210748 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9112/papers?page=15